Literature DB >> 7770117

Distribution of beta-amyloid protein in the brain following severe head injury.

D I Graham1, S M Gentleman, A Lynch, G W Roberts.   

Abstract

Deposits of beta-amyloid protein (beta AP) can be found in the brains of 30% of fatally head-injured patients; they have been found in children and after survival times of only 4 h. The principal aims of this study were to map the distribution of beta AP in 14 patients aged 65 years or less in whom it was known that the protein had been deposited, and to correlate its distribution with the pathologies of traumatic brain injury. The results show that beta AP is widely distributed, and that there is no correlation between its presence and cerebral contusions, intracranial haematoma, axonal injury, ischaemic brain damage, brain swelling or the pathology of raised intracranial pressure. These findings suggest that the deposition of beta AP is a consequence of the acute phase response of nerve cells to stress in susceptible individuals. Further studies will be required to establish the possible relationship between the deposition of beta AP following head injury and the molecular neuropathology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770117     DOI: 10.1111/j.1365-2990.1995.tb01025.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  37 in total

Review 1.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

2.  The possible role of hypoxia in the formation of axonal bulbs.

Authors:  B Kaur; G N Rutty; W R Timperley
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

3.  Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.

Authors:  D H Smith; M Nakamura; T K McIntosh; J Wang; A Rodríguez; X H Chen; R Raghupathi; K E Saatman; J Clemens; M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Brain Pathol       Date:  2011-09-12       Impact factor: 6.508

5.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

6.  Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy.

Authors:  Richard A Armstrong; Ann C McKee; Victor E Alvarez; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2016-10-21       Impact factor: 3.575

Review 7.  Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.

Authors:  Henrik Zetterberg; Douglas H Smith; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937

8.  Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Authors:  Hien T Tran; Laura Sanchez; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

9.  Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.

Authors:  Kunihiro Uryu; Xiao-Han Chen; Dan Martinez; Kevin D Browne; Victoria E Johnson; David I Graham; Virginia M-Y Lee; John Q Trojanowski; Douglas H Smith
Journal:  Exp Neurol       Date:  2007-07-10       Impact factor: 5.330

10.  Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma.

Authors:  Xiao-Han Chen; Robert Siman; Akira Iwata; David F Meaney; John Q Trojanowski; Douglas H Smith
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.